got up early and did the work. first ever marathon in the books ✅☄️ @1116sen @kanecornes @davidking34 #ballers #6.01
4
137
Thank you, Dennis Cometti, for all the iconic moments you called and the soundtrack you gave our great game.
When you’re up there, don’t forget to ask Pythagoras his thoughts on this 🎙️🏉📐
Rest In Peace
5
242
Giuseppe Di Giovanni retweeted
Our thoughts are with @CollingwoodFC, we never knew how difficult it was to travel once a year x
But if we’re all allowed to make our own rules now we’d love to play at the MCG more than once a year please @AFL.
I think there’s more boos at Adelaide Oval than the ghost train at the Royal Adelaide Show right now. #AFLCrowsPies #AFLFinals
5
780
Thank you for everything, @travisboak10! A Port Adelaide great and an inspiration beyond the footy field.
I’ll miss yelling “Captain’s goal!” whenever you had a shot at goal. Have yourself a career Boaky! 🏈🍐💐
2
134
Giuseppe Di Giovanni retweeted
Our paper has an editorial comment. We will go on a blind date with LP(a)!! @gdigiovanni_ @ProfSNicholls
What do recent observations reveal about the ‘blind date’ with Lp(a)-reducing drugs? academic.oup.com/eurjpc/arti…
Super proud to share my first ever first-author paper with you all! Grateful to everyone who has mentored and supported me along the journey 🙌🫀 @ProfSNicholls @julie_butters @MasashiFujino
New analysis from the @MonashVHI led HUYGENS study shows patients with high Lp(a) benefit most from evolocumab on top of statin therapy after a heart attack 🫀
➡️ Read the study: bit.ly/3FmCye9
Giuseppe Di Giovanni retweeted
冠動脈疾患における脂質管理は主にLDL-Cに焦点を当てています。テーラーメイド医療が目指される中、まだ道半ばと感じています。今回、HUYGENS試験のサブ解析を行い、冠動脈プラークの変化におけるApoB目標達成の重要性を明らかにしました。OAなので、ぜひご一読ください！
atherosclerosis-journal.com/…
Giuseppe Di Giovanni retweeted
この数年の脂質低下療法をまとめた総説を執筆しました。Treat-to-targetにも触れていますので、その用語が？な若手の先生は是非一読ください
J-STAGE Articles - New Approaches to Lipoproteins for the Prevention of Cardiovascular Events doi.org/10.5551/jat.RV22031
Giuseppe Di Giovanni retweeted
Victorian Heart Institute and Hospital Director @ProfSNicholls is leading world-first trials for genetic high cholesterol, expanding potentially life-saving treatments for those at risk of heart attack and stroke, presented at @American_Heart.
Read: bit.ly/3Zf4IyK
I am running 4 km every day of 2024 for my late father, for others fighting cancer and their loved ones @marypotterfound
If you'd like to donate please click the link below and follow my progress on @Strava
Day: 284/366
Total Run Distance: 1,191.1 km
mycause.com.au/p/356688/4km-…
2
7
332
Giuseppe Di Giovanni retweeted
Pleased to share the results of the NHMRC and NHF-funded COCOMO-ACS trial. Thanks to the patients, collaborators, site staff and funders who supported us. academic.oup.com/cardiovascr… @SACVRN @sahmriAU @atheroaussie @ProfSNicholls @ChrisBursill @heartfoundation @nhmrc @gdigiovanni_
I’ve been running 4km every day this year. So far, I’ve run 579km over 136 days. My goal is to keep this up for the whole year.
I’m doing this to help raise some funds, on behalf of my late father. If you’re able to support please click the link below.
walkforlove.org.au/fundraise…
8
651
Giuseppe Di Giovanni retweeted
The GOAL-ASIA Trial has just reached a significant milestone with 300 participants now on board 🌟 Our mission to attain LDL-C targets through a multifaceted intervention and boost heart health is gaining momentum. Thanks to all involved for their amazing support 🎉 #Amgen
Giuseppe Di Giovanni retweeted
Milestone Alert! 🌟 The GOAL-ASIA Trial, just recruited its 200th participant! We're on a mission to boost heart health and hit those LDL-C targets with a multifaceted intervention. Thanks to everyone involved for their incredible contributions 🎉 #Amgen
